Efficacy and Safety of Betamethasone Microsphere in Patients With Macular Edema Following Branch Retinal Vein Occlusion (HIKARI)
PHASE2/PHASE3CompletedINTERVENTIONAL
Timeline
Start Date
Not specified
Conditions
Macular Edema Following Branch Retinal Vein Occlusion
Interventions
DRUG
Betamethasone Microsphere (DE-102） Low Dose
DRUG
Betamethasone Microsphere (DE-102） High Dose
DRUG
Sham
Trial Locations (2)
Unknown
Santen study sites, Osaka
Santen study sites, Seoul
All Listed Sponsors
lead
Santen Pharmaceutical Co., Ltd.
INDUSTRY
NCT01512901 - Efficacy and Safety of Betamethasone Microsphere in Patients With Macular Edema Following Branch Retinal Vein Occlusion (HIKARI) | Biotech Hunter | Biotech Hunter